| scholarly article | Q13442814 |
| P50 | author | Barbara Budzynska | Q88091681 |
| Marta Kruk-Slomka | Q90027006 | ||
| Anna Boguszewska-Czubara | Q61117721 | ||
| Grażyna Biała | Q88019651 | ||
| P2093 | author name string | Tomasz Slomka | |
| P2860 | cites work | Free radicals and antioxidants in normal physiological functions and human disease | Q21710698 |
| Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630 | Q24672356 | ||
| Alzheimer's disease; taking the edge off with cannabinoids? | Q24681412 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Disorders of memory | Q28203017 | ||
| Identification and functional characterization of brainstem cannabinoid CB2 receptors | Q28276972 | ||
| Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression | Q28280373 | ||
| Mephedrone and nicotine: oxidative stress and behavioral interactions in animal models | Q28393490 | ||
| Adult neurogenesis transiently generates oxidative stress | Q28730206 | ||
| The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay | Q29616616 | ||
| Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice | Q30517938 | ||
| Rapid cell death is preceded by amyloid plaque-mediated oxidative stress | Q30539697 | ||
| Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. | Q33895436 | ||
| Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids | Q33933089 | ||
| The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages | Q33993080 | ||
| Nonpsychotropic cannabinoid receptors regulate microglial cell migration. | Q34179008 | ||
| Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks | Q34188588 | ||
| The pharmacologic and clinical effects of medical cannabis. | Q34326515 | ||
| Pharmacology of cannabinoid CB1 and CB2 receptors. | Q34442847 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| The endocannabinoid system and pain | Q34612917 | ||
| Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABA(A) receptors | Q34631608 | ||
| Effects of imperatorin on scopolamine-induced cognitive impairment and oxidative stress in mice | Q35075169 | ||
| Decreasing oxidative stress and neuroinflammation with a multifunctional peptide rescues memory deficits in mice with Alzheimer disease | Q35194113 | ||
| Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease. | Q35772355 | ||
| The endocannabinoid transport inhibitor AM404 differentially modulates recognition memory in rats depending on environmental aversiveness. | Q35841051 | ||
| The endocannabinoid system and its therapeutic exploitation | Q35876026 | ||
| Endocannabinoid system and stress and anxiety responses. | Q36145928 | ||
| AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor. | Q36176518 | ||
| The cannabinoid CB(1) receptor antagonist CE prolongs spatial memory duration in a rat delayed radial arm maze memory task | Q36961414 | ||
| Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats | Q36980744 | ||
| Cannabinoid transmission in the basolateral amygdala modulates fear memory formation via functional inputs to the prelimbic cortex. | Q50634645 | ||
| Effect of Cinnamomum zeylanicum extract on scopolamine-induced cognitive impairment and oxidative stress in rats. | Q50686924 | ||
| Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors. | Q50737314 | ||
| Involvement of nitric oxide in granisetron improving effect on scopolamine-induced memory impairment in mice. | Q50994757 | ||
| Influence of three-day morphine-treatment upon impairment of memory consolidation induced by cannabinoid infused into the dorsal hippocampus in rats | Q51035332 | ||
| Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. | Q52030065 | ||
| The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics. | Q52051961 | ||
| Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis | Q56638579 | ||
| The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis | Q69509899 | ||
| Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats | Q73398028 | ||
| Oxidative stress in Alzheimer's disease | Q87512835 | ||
| Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory | Q37140016 | ||
| Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome | Q37213114 | ||
| Endocannabinoid-mediated control of synaptic transmission | Q37363621 | ||
| Signal transduction of the CB1 cannabinoid receptor | Q37557059 | ||
| Oxidative stress and cognitive longevity | Q37677328 | ||
| Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease | Q37779106 | ||
| Cannabinoids, multiple sclerosis and neuroprotection | Q37960199 | ||
| Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids | Q38056395 | ||
| Antioxidant nutrients and age-related cognitive decline: a systematic review of population-based cohort studies | Q38112608 | ||
| The endocannabinoid system: an emotional buffer in the modulation of memory function | Q38175081 | ||
| Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic. | Q38196398 | ||
| Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. | Q40743568 | ||
| Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase | Q41316323 | ||
| Oxidative stress accelerates amyloid deposition and memory impairment in a double-transgenic mouse model of Alzheimer's disease. | Q41663034 | ||
| Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex | Q41905626 | ||
| Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study. | Q41906876 | ||
| Suppression of nitric oxide synthesis by L-NAME reverses the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice | Q42857099 | ||
| Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity. | Q43266820 | ||
| Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. | Q43278875 | ||
| Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory | Q43677116 | ||
| Common molecular and cellular substrates of addiction and memory | Q44297952 | ||
| SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task | Q44604750 | ||
| Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats. | Q44838508 | ||
| Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test. | Q45925485 | ||
| Activation of CB1 cannabinoid receptors impairs memory consolidation and hippocampal polysialylated neural cell adhesion molecule expression in contextual fear conditioning | Q46182584 | ||
| The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze | Q46464973 | ||
| Post-training CB1 cannabinoid receptor agonist activation disrupts long-term consolidation of spatial memories in the hippocampus | Q46772660 | ||
| Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats | Q46873828 | ||
| WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors | Q46889506 | ||
| Effects of imperatorin on nicotine-induced anxiety- and memory-related responses and oxidative stress in mice | Q47983987 | ||
| Role of cannabinoidergic mechanisms in ethanol self-administration and ethanol seeking in rat adult offspring following perinatal exposure to Delta9-tetrahydrocannabinol | Q48111868 | ||
| Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: mechanism of action and possible interactions with cholinergic system. | Q48119950 | ||
| Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice | Q48229623 | ||
| Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats | Q48322569 | ||
| Cannabinoids modulate hippocampal memory and plasticity | Q48433767 | ||
| Aversive memory reactivation engages in the amygdala only some neurotransmitters involved in consolidation. | Q48457188 | ||
| Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats. | Q48515994 | ||
| Influence of N-methyl D-aspartate receptor mechanism on WIN55,212-2-induced amnesia in rat dorsal hippocampus | Q48898539 | ||
| Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. | Q48973251 | ||
| Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses | Q49154401 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 9815092 | |
| P577 | publication date | 2015-12-29 | |
| P1433 | published in | Neural Plasticity | Q15716605 |
| P1476 | title | Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands | |
| P478 | volume | 2016 |
| Q58803432 | Acute MDMA and Nicotine Co-administration: Behavioral Effects and Oxidative Stress Processes in Mice |
| Q60933329 | Assessment of Improvement in Oxidative Stress Indices with Resocialization in Memory Retrieval in Y-Maze in Male Rats |
| Q42150000 | Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1 |
| Q104569007 | Efficacy of Cicuta virosa medicinal preparations against pentylenetetrazole-induced seizures |
| Q39031134 | Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes-a Short Review |
| Q37714575 | The Impact of CB2 Receptor Ligands on the MK-801-Induced Hyperactivity in Mice |
| Q37306525 | The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801 |
| Q90623137 | The role of CA1 CB1 receptors on lithium-induced spatial memory impairment in rats |
| Q52725432 | Zingiber zerumbet L. (Smith) extract alleviates the ethanol-induced brain damage via its antioxidant activity. |
Search more.